ArticleJournal of fish diseases2026
Investigating the Antiviral Mechanism of Kaempferol Against Grouper Iridovirus: Combined Evaluation of In Vitro Activity and In Vivo Efficacy.
Article in Journal of fish diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Singapore grouper iridovirus (SGIV) is one of the major pathogens that pose significant threats to the aquaculture industry. Kaempferol is a flavonoid compound extracted from Illicium verum Hook.f. (star anise), a material that is both edible and used in traditional medicine. In this study, we evaluated the antiviral effects of kaempferol against SGIV in vitro and in vivo, and elucidated the antiviral mechanism. Our study found that kaempferol could effectively resist SGIV infection in vitro and in vivo. Kaempferol might destroy the SGIV envelope and interfere with the attachment, invasion, and replication stages of SGIV infection. Transcriptomic analysis showed that differentially expressed genes regulated by kaempferol were enriched in ribosome, NF-κB, and phospholipase D signalling pathways. Further screening of immunity-related genes and pathway analysis revealed that antiviral immune responses were mainly governed by the JAK-STAT, PI3K-Akt, and TNF signalling pathways. This study demonstrated that kaempferol exhibited significant antiviral effects against SGIV through multiple mechanisms and had the potential to become an anti-SGIV fishery drug. These findings provide a theoretical basis for the development of effective drugs for the prevention and treatment of SGIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.